HY vs NBIX · rev $1.61B vs P/E 45, rev $1.77B
Hyster-Yale Materials Handling Inc (HY) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Hyster-Yale Materials Handling Inc (HY) is a farm & heavy construction machinery company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HY revenue for 2026-06-30 was $1.61B. Net income was -$62.1M. HY currently screens at market cap $617.9M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
HY currently screens at market cap $617.9M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the HY and NBIX stock pages for the full models.
Not investment advice.